Helen S. Kim

Helen S. Kim is the current Director at A2 Biotherapeutics. Helen has held various positions at different companies throughout their career.

Helen was previously a Member Board of Directors at Assembly Biosciences, Inc. from March 2018 to December 2020. Prior to that, they were a Partner at The Column Group from March 2018 to March 2019. Helen was also the Executive Vice President at Kite Pharma, Inc. from June 2014 to January 2018.

In addition, Helen has also been involved with Exicure as a Board Member from January 2014 to November 2020, and Forsight Vision 4 as a Board Member from January 2012 to January 2017.

Finally, they have also served as a Strategic Advisor and formerly Chief Business Officer at NGM Biopharmaceuticals, Inc. from August 2009 to November 2014, and as a Board Director at Sunesis Pharmaceuticals from July 2009 to February 2016.

Helen S. Kim received their MBA from the University of Chicago Booth School of Business and their BS in Chemical Engineering from Northwestern University.